Evidence map›Paper›PMID 35154113›Full record

ArticleFrontiers in immunology2022

Case Report: Altered NK Cell Compartment and Reduced CXCR4 Chemotactic Response of B Lymphocytes in an Immunodeficient Patient With HPV-Related Disease.

Margherita Doria, Giusella M F Moscato, Silvia Di Cesare, Gigliola Di Matteo, Mayla Sgrulletti, Françoise Bachelerie, Viviana Marin-Esteban, Viviana Moschese

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Margherita DoriaResearch Unit of Primary Immunodeficiency, Bambino Gesù Children's Hospital, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Giusella M F MoscatoInfectious Diseases Unit, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy.
Silvia Di CesareResearch Unit of Primary Immunodeficiency, Bambino Gesù Children's Hospital, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Gigliola Di MatteoDepartment of Medicine of Systems, University of Tor Vergata, Rome, Italy.
Mayla SgrullettiPediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy.
Françoise BachelerieUniversité Paris-Saclay, Inserm, Inflammation, Microbiome and Immunosurveillance, Clamart, France.
Viviana Marin-EstebanUniversité Paris-Saclay, Inserm, Inflammation, Microbiome and Immunosurveillance, Clamart, France.
Viviana MoschesePediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy.
Policlinico Tor Vergata · ITInserm · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of inborn errors of immunity (IEI) provides unique opportunities to elucidate the microbiome and pathogenic mechanisms related to severe viral infection. Several immunological and genetic anomalies may contribute to the susceptibility to develop Human Papillomavirus (HPV) pathogenesis. They include different acquired immunodeficiencies,

Indexed as

BiomarkersB-LymphocytesDisease SusceptibilityHumansKiller Cells, NaturalPapillomavirus InfectionsPrimary Immunodeficiency DiseasesReceptors, CXCR4BiomarkersCXCR4 protein, humanReceptors, CXCR4B lymphocytesCXCR4/CXCL12 axisHPVNK cellsWHIM

Identifiers

PMID35154113
PMCPMC8825485
OpenAlexW4210766517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.